FR2768345B1 - PRODUCT COMPRISING AT LEAST ONE DOUBLE-STRANDED RNA IN ASSOCIATION WITH AT LEAST ONE ANTI-VIRAL AGENT FOR THERAPEUTIC USE IN THE TREATMENT OF A VIRAL DISEASE, IN PARTICULAR OF A VIRAL HEPATITIS - Google Patents
PRODUCT COMPRISING AT LEAST ONE DOUBLE-STRANDED RNA IN ASSOCIATION WITH AT LEAST ONE ANTI-VIRAL AGENT FOR THERAPEUTIC USE IN THE TREATMENT OF A VIRAL DISEASE, IN PARTICULAR OF A VIRAL HEPATITISInfo
- Publication number
- FR2768345B1 FR2768345B1 FR9711543A FR9711543A FR2768345B1 FR 2768345 B1 FR2768345 B1 FR 2768345B1 FR 9711543 A FR9711543 A FR 9711543A FR 9711543 A FR9711543 A FR 9711543A FR 2768345 B1 FR2768345 B1 FR 2768345B1
- Authority
- FR
- France
- Prior art keywords
- viral
- association
- double
- treatment
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
Priority Applications (23)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9711543A FR2768345B1 (en) | 1997-09-17 | 1997-09-17 | PRODUCT COMPRISING AT LEAST ONE DOUBLE-STRANDED RNA IN ASSOCIATION WITH AT LEAST ONE ANTI-VIRAL AGENT FOR THERAPEUTIC USE IN THE TREATMENT OF A VIRAL DISEASE, IN PARTICULAR OF A VIRAL HEPATITIS |
ARP980103723A AR013269A1 (en) | 1997-08-04 | 1998-07-29 | PRODUCT CONTAINING AT LEAST A DOUBLE FILAMENT RNA COMBINED WITH AT LEAST AN ANTI-VIRAL AGENT, FOR THERAPEUTIC USE IN THE TREATMENT OF A VIRAL DISEASE, ESPECIALLY OF VIRAL HEPATITIS |
TW087112434A TW589189B (en) | 1997-08-04 | 1998-07-29 | Kit containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease, notably of viral hepatitis |
IL13427598A IL134275A0 (en) | 1997-08-04 | 1998-08-03 | Product comprising at least a double standed rna combined with at least an antiviral agent |
AU89872/98A AU750026B2 (en) | 1997-08-04 | 1998-08-03 | Product comprising at least a double stranded RNA combined with at least an antiviral agent |
US09/485,086 US6509154B1 (en) | 1997-08-04 | 1998-08-03 | Product comprising at least a double stranded RNA combined with at least an antiviral agent |
EP98941527A EP1001801B1 (en) | 1997-08-04 | 1998-08-03 | Product comprising at least a double stranded rna combined with at least an interferon for the treatment of viral hepatitis |
CA002299554A CA2299554A1 (en) | 1997-08-04 | 1998-08-03 | Product comprising at least a double stranded rna combined with at least an antiviral agent |
DK98941527T DK1001801T3 (en) | 1997-08-04 | 1998-08-03 | Product comprising at least one double-chain RNA combined with at least one interferon for the treatment of viral hepatitis |
JP2000506998A JP2001513514A (en) | 1997-08-04 | 1998-08-03 | Product containing at least one double-stranded RNA (dsRNA) in combination with at least one antiviral agent |
KR1020007001163A KR20010022572A (en) | 1997-08-04 | 1998-08-03 | Product Comprising at Least a Double Stranded RNA Combined with at Least an Antiviral Agent |
ES98941527T ES2171039T3 (en) | 1997-08-04 | 1998-08-03 | PRODUCT THAT INCLUDES AT LEAST A double-stranded RNA IN ASSOCIATION WITH AT LEAST ONE INTERFER FOR THE TREATMENT OF VIRAL HEPATITIS. |
AT98941527T ATE211393T1 (en) | 1997-08-04 | 1998-08-03 | COMPOSITION CONTAINING AT LEAST ONE DOUBLE STRAND RNA AND AT LEAST ONE INTERFERON FOR THE TREATMENT OF VIRAL HEPATITIS |
RU2000105336/14A RU2217161C2 (en) | 1997-08-26 | 1998-08-03 | Method for treatment of viral hepatitis |
PL98338377A PL338377A1 (en) | 1997-08-04 | 1998-08-03 | Product containing at least one double-string rna (ds rna) in combination with at least one antiviral agent |
CN98808902A CN1269725A (en) | 1997-08-04 | 1998-08-03 | Product comprising at least double stranded RNA combined with at least an antiviral agent |
PT98941527T PT1001801E (en) | 1997-08-04 | 1998-08-03 | A PRODUCT UNDERTAKING AT LEAST A DOUBLE SPIRAL RNA IN ASSOCIATION WITH AT LEAST AN INTERFERENCE FOR THE TREATMENT OF VIRAL HEPATITIS |
PCT/FR1998/001727 WO1999007409A1 (en) | 1997-08-04 | 1998-08-03 | Product comprising at least a double stranded rna combined with at least an antiviral agent |
DE69803391T DE69803391T2 (en) | 1997-08-04 | 1998-08-03 | COMPOSITION CONTAINING AT LEAST ONE DOUBLE STRANDED RNA AND AT LEAST ONE INTERFERON FOR THE TREATMENT OF VIRAL HEPATITIS |
HU0003384A HUP0003384A3 (en) | 1997-08-04 | 1998-08-03 | Product comprising at least a double stranded rna combined with at least an antiviral agent |
BR9811121-3A BR9811121A (en) | 1997-08-04 | 1998-08-03 | Product, pharmaceutical composition, and use of a product |
MYPI98003552A MY132954A (en) | 1997-08-04 | 1998-08-04 | Product containing at least one double-stranded rna combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease, notably of viral hepatitis |
NO20000555A NO20000555L (en) | 1997-08-04 | 2000-02-03 | Product containing at least one double stranded RNA combined with at least one antiviral agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9711543A FR2768345B1 (en) | 1997-09-17 | 1997-09-17 | PRODUCT COMPRISING AT LEAST ONE DOUBLE-STRANDED RNA IN ASSOCIATION WITH AT LEAST ONE ANTI-VIRAL AGENT FOR THERAPEUTIC USE IN THE TREATMENT OF A VIRAL DISEASE, IN PARTICULAR OF A VIRAL HEPATITIS |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2768345A1 FR2768345A1 (en) | 1999-03-19 |
FR2768345B1 true FR2768345B1 (en) | 2001-05-04 |
Family
ID=9511156
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR9711543A Expired - Fee Related FR2768345B1 (en) | 1997-08-04 | 1997-09-17 | PRODUCT COMPRISING AT LEAST ONE DOUBLE-STRANDED RNA IN ASSOCIATION WITH AT LEAST ONE ANTI-VIRAL AGENT FOR THERAPEUTIC USE IN THE TREATMENT OF A VIRAL DISEASE, IN PARTICULAR OF A VIRAL HEPATITIS |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2768345B1 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1326450C (en) * | 1985-08-26 | 1994-01-25 | William A. Carter | Modulation of aids virus-related events by double stranded rnas (dsrnas) |
PH24467A (en) * | 1987-03-03 | 1990-07-18 | Hem Res Inc | Synergistics interplay of lymphokines and dsrnas |
US4950652A (en) * | 1987-03-23 | 1990-08-21 | Hem Research, Inc. | dsRNAs for combination therapy in the treatment of viral diseases |
AU1820588A (en) * | 1987-07-17 | 1989-01-19 | Hem Research, Inc. | Double-stranded rna correction of abnormalities in circulating immune complexes and monocyte function |
DE3853755T2 (en) * | 1987-09-04 | 1995-12-14 | Hem Pharma Corp | Diagnosis of deficiency states of double-stranded RNA. |
US5132292A (en) * | 1990-05-25 | 1992-07-21 | Hem Research, Inc. | Treatment of viral hepatitis |
-
1997
- 1997-09-17 FR FR9711543A patent/FR2768345B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FR2768345A1 (en) | 1999-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9811121A (en) | Product, pharmaceutical composition, and use of a product | |
CA2165821A1 (en) | Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection | |
DK188991D0 (en) | THERAPEUTIC EFFECTIVE SHORT, DOUBLE-STRENGTH RNA | |
MA26790A1 (en) | DIETETIC OR PHARMACEUTICAL COMPOSITION FOR USE IN THE PREVENTION OR TREATMENT OF HYPER-OXALURIA | |
WO1999049883A3 (en) | Oxidized thymosin beta 4 | |
FR2774687B1 (en) | LIPOPEPTIDES CONTAINING A FRAGMENT OF THE INTERFERON GAMMA, AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS | |
MA26608A1 (en) | PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEART FAILURE. | |
DZ3014A1 (en) | Medicines for the treatment of hypertension. | |
FR2768345B1 (en) | PRODUCT COMPRISING AT LEAST ONE DOUBLE-STRANDED RNA IN ASSOCIATION WITH AT LEAST ONE ANTI-VIRAL AGENT FOR THERAPEUTIC USE IN THE TREATMENT OF A VIRAL DISEASE, IN PARTICULAR OF A VIRAL HEPATITIS | |
FR2768344B1 (en) | PRODUCT COMPRISING AT LEAST ONE DOUBLE-STRANDED RNA IN ASSOCIATION WITH AT LEAST ONE ANTI-VIRAL AGENT FOR THERAPEUTIC USE IN THE TREATMENT OF A VIRAL DISEASE | |
FR2766715B1 (en) | PRODUCT INCLUDING AT LEAST DOUBLE-STRANDED RNA IN ASSOCIATION WITH AT LEAST ONE ANTI-VIRAL AGENT FOR SIMULTANEOUS THERAPEUTIC USE, SEPARATE OR OVER TIME, IN THE TREATMENT OF A VIRAL DISEASE | |
DZ2564A1 (en) | Pharmaceutical compositions for the treatment of diabetes mellitus and associated conditions. | |
FR2684552B1 (en) | USE OF D-FENFLURAMINE AND FENFLURAMINE DERIVATIVES IN THE TREATMENT OF HYPERTENSION IN INSULIN RESISTANT SUBJECTS. | |
FR2720944B1 (en) | Therapeutic or dietetic composition in the form of a medicated gel for administration to pets. | |
FR2826261B1 (en) | TOPICAL COMPOSITION COMPRISING A CYTOTOXIC PRODUCT AND ITS USE IN THE TREATMENT OF ALOPECHE | |
EP0678578A3 (en) | Multiple drug resistance gene of Aureobasidium pullulans. | |
FR2702149B1 (en) | Application of lamotrigine in the treatment of neuro-AIDS. | |
FR2766711B1 (en) | PRODUCT COMPRISING AT LEAST ONE DOUBLE-STRANDED RNA IN ASSOCIATION WITH AT LEAST ONE DEVIRE OF 6-BENZYLURACIL FOR SIMULTANEOUS THERAPEUTIC USE, SEPARATE OR SPREAD OVER TIME | |
FR2733913B1 (en) | DNA SEQUENCE AS A MEDICAMENT, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | |
FR2709964B1 (en) | Antiviral pharmaceutical compositions proposed in the treatment of AIDS and Herpes. | |
FR2702151B1 (en) | Application of anti-convulsants in the treatment of neuro-AIDS. | |
FR2795732B1 (en) | USE OF THE KRIT1 GENE IN THE FIELD OF ANGIOGENESIS | |
Alcorn | Rift over viral load data and clinical guidelines | |
LTIP1943A (en) | Arylating agents, used in the treatment of cancerand disease caused by viral infection | |
巩佳 | Why is it wrong to have two mums? |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |